LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewBose acquired SkullcandyMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESG
Open App
Agreement signedAgreed 22 Aug 2022

Alcon Research, LLC /
Aerie Pharmaceuticals, Inc.

Alcon Research, LLC agrees to buy Aerie Pharmaceuticals, Inc.

Terms
Not stated
Stage
Agreement signed
Buy side: Alcon Research, LLC
Buy sideAlcon Research, LLC
Target: Aerie Pharmaceuticals, Inc.
TargetAerie Pharmaceuticals, Inc.
Source · 22 Aug 2022
See the source
Buy side: Alcon Research, LLC
Buy sideAlcon Research, LLC
Target: Aerie Pharmaceuticals, Inc.
TargetAerie Pharmaceuticals, Inc.
01 / BuyerAlcon Research, LLC
02 / TargetAerie Pharmaceuticals, Inc.
01

What happened

Alcon Research, LLC agreed to acquire Aerie Pharmaceuticals, Inc. for $15.25 per Share, according to a filing dated Nov. 21, 2022.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Alcon Research, LLC agrees to buy Aerie Pharmaceuticals, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.